1CG

4.76%

1.1¢ one click group limited

Key activities since late 2020, page-2

First 2 Last

Share
Profile

Follow
CJTJ

7,831 Posts.

2295

20/02/21

17:25

Post #: 51183100
Share
Originally posted by chartorscience: ↑

Thought I would pull a post together with some key information on UUVs activities since late 2020.

1. Changes to the Board

The Dec-20 quarterly noted a number of key changes to the board which signal an end to the aquatic drone focus:
Outgoing - Peter James (UUV Chairman from the UUV IPO), Rear Admiral Jay Cohen (Director from the UUV IPO and former nuclear submarine commander) and Robert Clisdell.
Incoming - This quarter saw Winton Willesee appointed as Chairman and Erlyn Dale and James Bahen appointed as Directors of UUV.

2. Current state of affairs

The Dec-20 quarterly also included some key information about operations moving forward:
Cessation of ATC - "UUV's wholly-owned, US-based subsidiary Aquabotix Technology Corporation(“ATC”) has ceased the active conduct of its business operations during the period." The quarterly also noted that all ATC-related legal issues have been resolved as a result of bankruptcy of ATC.
Cash burn - While UUV spent ~$400k over the last quarter, this was primarily tied to the wind-up of ATC. The report notes "The Company notes that with the end of trading for ATC the cash requirements of the Company will decrease significantly."
Next steps - "The Company is now well funded for its next chapter of development." and "Having cease its operations in the US it is now seeking
new opportunities."

3. Looking forward

It is worth looking into the background of the new Directors to understand how UUV may be repositioned.
Winton Willesee/Erlyn Dale - considerable Board experience on a range of ASX-listed companies. In particular, both Winton and Erlyn head up Azalea Consulting, which is a company focused on Company Director/Secretary services. Through this consulting service they have had the opportunity to work with and sit on the Boards of a range of ASX companies including Nanollose (NC6), Creso Pharma (CPH) and New Zealand Coastal Seafoods (NZS). One interesting thing to note is the role Winton/Erlyn played in executing a Reverse Take Over (RTO) of NZS from a shell company called xTV Networks. Winton led this RTO through his role on the board of xTV which was effectively a shell at that point in time.
James Bahen - James is an Executive at SmallCap Corporate. This consultancy notes that their "core competency is providing Corporate Advisory, IPO and RTO Management services to our clients". James' past experience seems to be linked to mining companies but it's not hard to see why he has been brought on.
The outstanding question would be what will UUV reposition into from a sector perspective. The recent appointment of both Winton and Erlyn to the AR9 board to strengthen governance and compliance could hold a clue but unsure exactly how linked this may be.

In terms of the chart/large volumes over the past few weeks, I covered that in my chart post here.

Expand

hey mate, great work, thank you for taking your time to post this summery.

At these prices absolutely worth having a go..in my opinion.

Winton and Erlyn appointment to AR9 has also go me thinking and exited to find out where this company is heading, like I said before a name change is required asap and this could give us a clue on where we are heading ..

cheers mate.
UUV Price at posting: 0.3¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

There are more pages in this discussion • 81 more messages in this thread...

First 2 Last

Add 1CG (ASX) to my watchlist

(20min delay)
Last 1.1¢		Change 0.001(4.76%)		Mkt cap ! $8.522M

Open	High	Low	Value	Volume
1.0¢	1.1¢	1.0¢	$1.823K	173.3K

Buyers (Bids)

No.	Vol.	Price($)
1	99987	1.0¢

Sellers (Offers)

Price($)	Vol.	No.
1.1¢	1074648	1

View Market Depth

No.	Vol.	Price($)
1	99987	0.010
12	3320742	0.009
10	3468596	0.008
8	1164570	0.007
3	552500	0.006

Price($)	Vol.	No.
0.011	1074648	1
0.012	1043078	3
0.013	885218	3
0.014	1500000	2
0.015	2843333	3

Last trade - 16.10pm 04/10/2024 (20 minute delay)

1CG (ASX) Chart

Key activities since late 2020, page-2

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Key activities since late 2020, page-2

Top Stories

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News